Home › Services › Serrated polyposis syndrome
Condition
Serrated polyposis syndrome
Serrated polyposis syndrome is the diagnosis made when someone has enough serrated polyps in the bowel, counted across all their colonoscopies rather than within any one of them. It is the commonest polyposis syndrome of the bowel, it is frequently missed, and it is managed by clearing the polyps and keeping ahead of them rather than by surgery. A/Prof Viraj Kariyawasam has a particular research interest in serrated polyps and the serrated pathway.
What serrated polyposis syndrome is
Serrated polyps are a family of growths in the bowel lining with a sawtooth outline under the microscope. Most people who have one have one, or a few, and they are removed at colonoscopy and that is the end of it. The whole subject is covered on the sessile serrated polyps page.
Serrated polyposis syndrome is what happens at the other end of that range. Some people form them in numbers, over years, across the whole colon. There is no blood test and no single appearance that makes the diagnosis. It is made by counting, and the count runs across every colonoscopy a person has had rather than within one of them.
It is the commonest polyposis syndrome of the bowel, more common than all the other gastrointestinal polyposis syndromes put together, and it is found in about one person in 250 having a screening colonoscopy. Among people having colonoscopy after a positive stool test the figure is higher, up to about one in 111 in European studies.
The name carries more alarm than the condition usually warrants. It is not a cancer diagnosis, it is not inherited in the way most people assume a syndrome must be, and for the great majority of people it is managed entirely at colonoscopy.
The counting definition
The World Health Organization set the definition in the fifth edition of its classification, published in 2019. It is met by either of two patterns:
- Type 1: five or more serrated polyps proximal to the rectum, all of them 5 mm or larger, with at least two of them 10 mm or larger.
- Type 2: more than 20 serrated polyps of any size distributed throughout the large bowel, with at least five of them proximal to the rectum.
All types of serrated polyp count towards the total, including hyperplastic polyps, which are the kind usually dismissed as harmless. Within the syndrome most of the polyps are hyperplastic polyps and sessile serrated lesions; traditional serrated adenomas are uncommon. A hyperplastic polyp of 10 mm or more is generally managed as though it were a sessile serrated lesion.
The two patterns are not equivalent. People who meet Type 1, and people who meet both, carry a higher bowel cancer risk than people who meet Type 2 alone. Type 2 has the stronger association with smoking.
One detail in the 2019 revision is worth knowing, because it changed where endoscopists look. In serrated polyposis syndrome, about half of bowel cancers arise in the rectum and sigmoid, which is the opposite of the pattern for sporadic serrated lesions. Recognising that led the 2019 criteria to place more weight on lesions in the sigmoid than the earlier version did.
Why it gets missed
The diagnosis is missed often, and the reason is structural rather than careless.
The count is cumulative. Someone with four serrated polyps at one colonoscopy and three at another meets Type 1 if the sizes fit, even though neither report looked remarkable on its own. Unless somebody adds up the numbers, the sizes and the locations across several reports, the threshold is crossed without anyone noticing.
Because of that, guidelines now ask that the number, size and location of serrated polyps be written into every procedure report until the question is settled, so the arithmetic can be done later. In referral centres, most people eventually recognised as having the syndrome had already had enough polyps removed by their original doctor to make the diagnosis. The polyps were found. The adding up was not done.
Detection is the other half of it. Serrated lesions are pale, flat and easy to overlook, and detection rates vary widely between endoscopists. The 2026 international consensus recommends that anyone known to have the syndrome has their colonoscopy done by an endoscopist whose detection rate for sessile serrated lesions is documented and at least 6 per cent.
If you have had several colonoscopies with serrated polyps removed, it is worth bringing all the reports to one appointment so the counting can be done properly.
Who gets it, and why
The average age at diagnosis is around 60. Men and women are affected roughly equally, though some series have found more women than men.
Smoking has a strong association with the syndrome, stronger with Type 2 than Type 1. That said, plenty of people with the syndrome have never smoked, so it is not an explanation that fits everyone, and nobody should be made to feel it is their doing. There is also, at present, no evidence that stopping smoking changes the course of the syndrome once it is established. Stopping is still worth doing, for the risk of forming further polyps and for every other reason.
Beyond that, the honest answer is that the cause is not known. Despite a good deal of searching, no inherited gene fault has been found that accounts for more than a small minority of cases.
What the bowel cancer risk actually is
The figure used in Australian patient information is about a 20 per cent chance of bowel cancer over a lifetime. That number is accurate and, on its own, misleading. The shape of the risk matters more than its size.
A systematic review of 36 studies covering 2,788 people put the overall risk at 19.9 per cent, with a 95 per cent confidence interval of 15.3 to 24.5 per cent. Splitting it up changes the picture entirely:
- 14.7 per cent was cancer found at the time the syndrome was diagnosed.
- 7 per cent had already had a bowel cancer before the diagnosis was made.
- 2.8 per cent was cancer arising during surveillance, after the colon had been cleared and follow-up had started.
In other words, most of the 20 per cent is cancer that had already happened by the time anyone knew the syndrome was there. It is an argument for finding the syndrome earlier. It is not a forecast for somebody already in a surveillance programme.
The surveillance figures have improved as the technique has. Across nine published series of more than 60 patients each, the risk of bowel cancer during surveillance over roughly five years ranged from zero to 7 per cent, and sat at or below 2 per cent in seven of the nine, with several recent studies finding no cancers at all. A Spanish randomised trial published in 2026, comparing two-year and three-year intervals in people with no advanced lesion at their last colonoscopy, found no bowel cancer in either arm.
That trial also found that risk is highest in the first few years after diagnosis and appears to settle after that, which is why the early colonoscopies come closer together.
The clearing phase
Management runs in two phases, and knowing which one you are in explains the appointment schedule better than any interval does.
The first is the clearing phase. The aim is to remove everything that needs removing, which usually cannot be done in one sitting. Colonoscopy is repeated every three to six months until the colon is clear, which typically takes two to four examinations. Australian guidance puts the endpoint at two consecutive colonoscopies finding no polyps.
What gets removed is not every polyp in the bowel. The targets are all conventional adenomas, all lesions above the sigmoid, and serrated polyps in the rectum and sigmoid above a size threshold set at the time. Very small distal hyperplastic polyps are generally left.
It is more work than an ordinary colonoscopy, and worth knowing about in advance. Published series average ten to sixteen polyp removals per colonoscopy during the clearing phase, falling to five to seven per colonoscopy once surveillance starts. In one study, 5 per cent of people needed more than a hundred lesions removed in total before the colon was clear.
Most of these are small and come off with a cold snare, which means without diathermy, and that approach has fewer complications than the alternatives. Larger or flatter lesions need endoscopic mucosal resection.
The surveillance phase
Once the colon is clear, colonoscopy moves to every one to two years, with anything 5 mm or larger removed as it appears. Where the interval sits inside that range depends on what the last examination found.
Yearly if the last colonoscopy found a lesion of 20 mm or more, three or more lesions of 10 to 19 mm, a sessile serrated lesion containing dysplasia, a traditional serrated adenoma, or an advanced conventional adenoma. Australian guidance adds more than five relevant polyps to that list.
Two-yearly if there were no more than two lesions of 10 to 19 mm and the smaller polyps are under good control.
Three-yearly can be considered where only small lesions are being found and the polyp burden has become very small and stayed that way over several examinations. This is the cautious end of current practice rather than a settled recommendation, and the 2026 Spanish trial could not demonstrate that three years is as safe as two.
Surveillance does not go on being this intensive forever in everyone. The risk falls with time since diagnosis, and the interval is reviewed as that happens.
When surgery is considered
Surgery is the exception rather than the direction of travel, and current guidance is explicit about that. For someone without a bowel cancer, the 2026 international consensus recommends managing the polyps endoscopically in preference to operating, and recommends that anyone whose polyp burden looks unmanageable is referred to an expert in advanced endoscopic resection before surgery is considered.
The two situations that do lead to surgery are a cancer, and a polyp burden that can no longer be kept up with at colonoscopy.
Two facts are worth holding alongside each other. Surgery to remove large parts of the bowel for benign polyps is not a small undertaking: in one nationwide study, complications followed 13 per cent of these operations, with mortality between 0.3 and 0.5 per cent. And it does not end surveillance, because polyps keep forming in whatever bowel remains. In one series, 17.9 per cent of people who had the colon removed went on to develop an advanced lesion in the retained rectum.
Against that, the endoscopic approach works. In one series following people on intensive surveillance, three of 41 needed surgery over five years, and no cancer developed in that time.
The appendix question
Serrated lesions are common in the appendix in people with this syndrome, and they generally cannot be seen at colonoscopy. That sounds alarming and is usually not.
Cancer of the appendix in serrated polyposis syndrome is rare, and no consensus has formed that the appendix should be removed as a precaution. The 2026 consensus states the position plainly: prophylactic appendicectomy is not currently warranted.
It is raised here because it comes up, and because the honest answer is that this is a known feature of the condition that is being watched rather than acted on.
What it means for family
First-degree relatives, meaning parents, brothers and sisters, and children, have a raised bowel cancer risk and should be offered colonoscopy rather than relying on the stool test alone. The stool test looks for blood, and serrated polyps are among the least likely to bleed.
Australian guidance sets the starting point at whichever of these comes first: age 40, the youngest age at which anyone in the family was diagnosed with the syndrome, or ten years younger than the youngest bowel cancer in the family. If that first colonoscopy finds nothing, five-yearly is reasonable. If it finds polyps, the interval shortens to between one and three years depending on what was found. The 2026 international consensus sets out much the same approach.
On the size of the risk, the studies point the same way without agreeing on a figure. Several have found bowel cancer risk in first-degree relatives raised around fivefold, including a population database study that also found a tenfold increase in people with the syndrome themselves. Others have found more modest differences, and the 2026 consensus describes the evidence for increased screening of relatives as currently mixed. What is not in dispute is that colonoscopy rather than the stool test is the right test for them.
An earlier version of the WHO criteria included a third pattern, having a serrated polyp above the sigmoid in a first-degree relative of someone with the syndrome. That was dropped in 2019. People in that position are now looked after as relatives rather than as having the syndrome themselves, and the evidence suggests they still warrant colonoscopy, so the change was about naming rather than about discharging anyone.
Genetic testing
Genetic testing is not routine, and that surprises people who expect a syndrome to have a gene behind it.
Despite considerable effort, no consistent inherited cause has been found. One gene, RNF43, was identified in a single severely affected family, but systematic testing of people with the syndrome has not found germline faults in it. In a series of 258 people with the syndrome who had genetic testing, four had a germline variant of any kind, three of them in genes associated with a different condition entirely.
So the 2026 international consensus recommends genetic testing only where something else in the picture calls for it: a large number of conventional adenomas as well as the serrated polyps, more than two hamartomatous polyps, or a family history suggesting a known inherited cancer syndrome. Australian guidance takes the same position, adding a traditional serrated adenoma or a family history of the syndrome itself as reasons to involve a genetics service.
Having the syndrome does not, by itself, mean a genetics referral is needed.
Living with it, and getting the most out of appointments
The practical reality of this diagnosis is a run of colonoscopies closer together than anyone would choose, followed by a long period of regular but less frequent ones. The preparation is the hard part rather than the procedure.
Two things make the follow-up work better. The first is keeping every report. The counting that defines the syndrome, and the decisions about intervals afterwards, both depend on knowing what was found and when, and reports scatter between practices over the years.
The second is deciding who holds the thread. Surveillance works best when one doctor is following the whole picture rather than each colonoscopy being considered on its own.
Australian patient information notes that daily aspirin is sometimes recommended for people with this syndrome to reduce bowel cancer risk. That is a conversation to have with your own doctor rather than something to start independently, since aspirin carries its own risks.
Worth bringing to an appointment:
- every previous colonoscopy report and pathology report you can find
- how many polyps were removed each time, and how large the largest was
- whether any report mentioned dysplasia
- whether anyone in the family has had bowel cancer or bowel polyps, and at what age
- whether you smoke, and whether you would like help stopping
Related pages
Common questions
The questions people actually ask, answered plainly.
How many serrated polyps does it take to be diagnosed?
Either five or more above the rectum, all 5 mm or larger with at least two of them 10 mm or larger, or more than 20 anywhere in the large bowel with at least five above the rectum. The counts add up across every colonoscopy you have had, not within one, which is why old reports matter. All types of serrated polyp count, including hyperplastic polyps.
I have a lot of polyps but do not quite meet the criteria. Does that mean I am fine?
Not quite fine and not the same as having the syndrome. The criteria draw a sharp line and biology does not. People whose numbers approach the threshold without reaching it also carry some increased risk and are followed accordingly rather than discharged. It is also worth having old reports checked, since the threshold is sometimes crossed on paperwork nobody has added up.
Is it inherited? Will I pass it on?
No single inherited gene fault has been found that accounts for it, and genetic testing is not routine. What is true is that close relatives have a raised bowel cancer risk and should be offered colonoscopy. That is a different thing from passing on a known faulty gene, and it is why the advice to family is about screening rather than about testing.
Will I need my bowel removed?
Usually not. Current guidance is explicit that where there is no cancer, managing the polyps at colonoscopy is preferred to operating, and that anyone whose polyp burden looks unmanageable should first be referred to someone who specialises in advanced endoscopic removal. In one series following people on intensive surveillance, three of 41 needed surgery over five years, and no cancer developed in that time.
Why do I need colonoscopies every three to six months at first?
That is the clearing phase, and it is temporary. The aim is to remove everything that needs removing, which usually cannot be done in one sitting, and it typically takes two to four examinations. Once the colon is clear the interval moves out to one or two years. Risk is also highest in the first few years after diagnosis, which is the other reason the early examinations come close together.
Does having this mean I will get bowel cancer?
No. The lifetime figure quoted in Australian patient information is about 20 per cent, and most of that is cancer already present when the syndrome is first found rather than cancer arising later. Once the colon has been cleared and surveillance has started, the risk measured across published series over about five years ran from zero to 7 per cent, and was at or below 2 per cent in most of them.
Should my children be tested or screened?
Screened, not tested. Colonoscopy rather than the stool test, starting at whichever comes first of age 40, the youngest age anyone in the family was diagnosed with the syndrome, or ten years younger than the youngest bowel cancer in the family. If the first colonoscopy is clear, five-yearly is reasonable; if polyps are found, the interval shortens to between one and three years.
Does my appendix need to come out?
No. Serrated lesions are common in the appendix in this syndrome and usually cannot be seen at colonoscopy, but cancer of the appendix here is rare and there is no consensus that the appendix should be removed as a precaution. The 2026 international consensus says plainly that prophylactic removal is not warranted.
Is smoking the cause?
It is strongly associated, more so with the pattern involving many smaller polyps, but plenty of people with this syndrome have never smoked, so it is not the explanation in everyone. There is also no evidence yet that stopping changes the course of the syndrome once it is established. Stopping is still worth doing, for the risk of forming further polyps and for every other reason.
Can I stay with my usual endoscopist?
That is worth a conversation rather than an assumption. These lesions are harder to see than ordinary polyps and detection varies between endoscopists, so the 2026 international consensus recommends that colonoscopy in this syndrome is done by someone whose detection rate for sessile serrated lesions is documented and at least 6 per cent. It is a reasonable thing to ask about.
Where these figures come from
- Rex DK et al, Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2026
- Serrated polyposis syndrome, risk management. eviQ, Cancer Institute NSW, ID 1373, reviewed September 2025
- Facts for people and families with serrated polyposis syndrome. eviQ, Cancer Institute NSW
- Muller C et al, Risk of colorectal cancer in serrated polyposis syndrome, a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2022;20(3):622-630.e7
- Lopez-Vicente J et al, Endoscopic surveillance in serrated polyposis syndrome, two or three-year intervals, a non-inferiority randomized trial. Dig Dis Sci 2026;71(9):4077-87
- Rodriguez-Alcalde D et al, High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome. Endoscopy 2019;51(2):142-51
- Kanth P et al, Cancer risk in patients with and relatives of serrated polyposis syndrome and sporadic sessile serrated lesions. Am J Gastroenterol 2022;117(2):336-42
- Bleijenberg AGC et al, The (ir)relevance of the abandoned criterion II for the diagnosis of serrated polyposis syndrome. Fam Cancer 2020;19(2):153-60
- IJspeert JEG et al, Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts, a European overview. Gut 2017;66(7):1225-32
- East JE et al, British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut 2017;66(7):1181-96
- Nagtegaal ID et al, The 2019 WHO classification of tumours of the digestive system. Histopathology 2020;76(2):182-8
This page is general information. It is not advice about your own situation, and it is not a substitute for seeing a doctor. If you have symptoms, see your GP.
Make an appointment
Appointments are booked through the rooms directly. Have your GP referral ready when you call or ask your GP to send it ahead. Urgent inflammatory bowel disease, rectal bleeding and positive bowel screening referrals are prioritised.
Norwest & Rouse Hill (02) 8530 1800 Pennant Hills (02) 9875 2311 Macquarie Park (02) 9812 3880